Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
105.00    -2.50 (-2.33%)
Bid:
104.00
Ask:
109.50
Spread: 5.50 (5.288%)
Market Cap: £103.48m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Trading Update

15 May 2025 07:00

RNS Number : 7225I
Eurocell plc
15 May 2025
 

15 May 2025

EUROCELL PLC

("Eurocell" the "Group" or the "Company")

Trading Update

 

Eurocell plc, the market leading, vertically integrated UK manufacturer, distributor and recycler of innovative window, door and roofline products, provides the following update for the first four months of 2025, in advance of the Annual General Meeting ("AGM") later today.

 

Summary

Trading conditions in our key markets have been mixed. There are some signs of an improving picture in new build housing, but we are still experiencing lower than expected demand in our core RMI market. We therefore continue to focus on further cost reduction and operational improvements to drive more efficiencies and mitigate against the impact of delayed market recovery.

 

We are making good progress with the execution of our growth strategy and are pleased to see this coming through in the sales performance of our key initiatives.

 

As we consider the outlook for the remainder of the year, recognising the potential adverse impact of macroeconomic conditions on volumes, particularly RMI, we now expect adjusted profit before tax for the year in the core business to show nominal improvement over 2024, before any impact from the Alunet acquisition. We expect Alunet to deliver a net increase in the Group's adjusted profits in line with our plans, reflecting strong market share gains already achieved this year.

 

Our balance sheet is strong and the actions we have taken, including those on costs and cash flow, position us well to benefit when our end markets fully recover.

 

Trading Performance

Excluding Alunet, Group sales for the four months to 30 April 2025 were level(1) with 2024, with volume down 1%. Including Alunet, Group sales were up 8%(1). Comparisons by division were:

 

Sales to 30 April 2025

vs 2024(1)

Profiles Division

+1%

Branch Network Division

Level

Group, excluding Alunet

Level

Total Group, including Alunet

+8%

(1) On a trading day adjusted basis

 

Profiles - sales up 1%, with volume down 2%, reflecting reduced RMI activity through our trade fabricators, partially offset by some modest improvement in the new build housing market.

 

Branch Network - sales level with 2024, with volume down 1%, reflecting:

Underlying Branch Network sales to the RMI market down 4%

Offset by the benefits of progress with our strategic initiatives for window and door sales (up 7%), garden rooms (up 29%) and e-commerce activity (up 51%), with the contribution to date from new branches not yet material

 

We opened two new branches at the end of last year, plus a further four so far in 2025, with three more to come in the first half. Together with three relocations already completed this year, this creates a short-term drag, but enables longer-term profit improvement.

 

Alunet - market share gains driving strong sales growth in line with our plans:

Alunet Systems secured new business with nine Eurocell fabricators, successfully launched the new Aluna+ aluminium window system in April, with the new Iconiq aluminium roof lantern launch planned for June. As a result, we anticipate that sales will continue to build in H2 

Comp Door has continued to acquire new installers. The new Sleekskin door has been well received by the trade and we expect the business to benefit from cross-selling opportunities and supply chain synergies with Vista

 

Input cost prices have remained stable, including electricity (where we operate a rolling 12-month forward hedging policy for the majority of our requirements), recycling feedstock, and PVC resin.

 

We continue to see inflation elsewhere, particularly labour costs, which include the increases to employers' National Insurance and the National Living Wage from April 2025.

 

In order to offset this inflation, we have implemented selling price increases and taken other management actions, including cost reductions. The branch network restructuring announced with our preliminary results in March is now complete, generating annualised savings of c.£2 million. In addition, we have now identified further overhead cost reductions to be realised in 2025 of c.£2 million.

 

Capital Allocation

In line with our strategy, significant investments in the next 12 months include delivering the project to modernise our IT infrastructure, which remains on track, and further new branch openings.

 

We are committed to driving shareholder returns through a combination of a progressive ordinary dividend and supplementary distributions (currently via share buybacks) where appropriate, whilst always seeking to maintain a strong financial position.

 

Good cash flow management underpinned the successful delivery of a £15 million share buyback programme substantially in 2024. The new £5 million share buyback announced on 20 March 2025 has progressed well. As of 14 May 2025, we had purchased approximately 0.9 million ordinary shares at a cash cost of £1.4 million and we expect to complete this buyback during the second half.

 

 

This announcement contains inside information for the purpose of the assimilated Market Abuse Regulation (EU) 596/2014 as it forms part of the law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

Enquiries:

Eurocell plc

Darren Waters, Chief Executive Officer +44 (0) 1773 842 105

Michael Scott, Chief Financial Officer +44 (0) 1773 842 140

Teneo

Nick de Bunsen +44 (0) 7825 575 258

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDUXUBDGUS
Date   Source Headline
13th Mar 20207:00 amRNSPreliminary Results for the year ended 31 Dec 2019
11th Mar 20203:59 pmRNSTransaction in Own Shares
10th Mar 20204:34 pmRNSBlock listing Interim Review
7th Jan 202012:29 pmRNSForm 8.3 - Eurocell PLC
11th Dec 20197:00 amRNSTrading Update
9th Dec 20199:44 amRNSHolding(s) in Company
21st Oct 20191:16 pmRNSHolding(s) in Company
17th Oct 20193:26 pmRNSHolding(s) in Company
17th Oct 20193:11 pmRNSHolding(s) in Company
1st Oct 20197:00 amRNSTotal Voting Rights
20th Sep 20195:33 pmRNSDirector/PDMR Shareholding
5th Sep 20195:49 pmRNSBlock listing Interim Review
14th Aug 20192:55 pmRNSHolding(s) in Company
6th Aug 20191:04 pmRNSHolding(s) in Company
6th Aug 201912:42 pmRNSHolding(s) in Company
2nd Aug 20194:00 pmRNSHolding(s) in Company
2nd Aug 20192:35 pmRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSHalf year results for six months ended 30 Jun 2019
9th Jul 201911:27 amRNSHolding(s) in Company
24th Jun 20192:23 pmRNSHolding(s) in Company
24th Jun 201911:31 amRNSHolding(s) in Company
10th May 20194:06 pmRNSResult of AGM
10th May 20197:00 amRNSAGM Trading Update
25th Apr 20193:34 pmRNSDirector/PDMR Shareholding
17th Apr 20197:00 amRNSNotice of AGM
22nd Mar 20192:23 pmRNSTransaction in Own Shares
15th Mar 20197:00 amRNSResults for the year ended 31 December 2018
8th Mar 20197:00 amRNSBlock listing Interim Review
14th Dec 20182:25 pmRNSHolding(s) in Company
12th Dec 20187:00 amRNSTrading Update
14th Sep 201810:02 amRNSDirectorate Change
6th Sep 20187:00 amRNSBlock listing Interim Review
13th Aug 20183:12 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSResults for the six months ended 30 June 2018
27th Jun 20184:58 pmRNSHolding(s) in Company
18th May 20182:52 pmRNSResult of AGM
18th May 20187:00 amRNSAGM Trading Update
16th May 20184:48 pmRNSDirector/PDMR Shareholding
27th Apr 201812:02 pmRNSHolding(s) in Company
27th Apr 201812:01 pmRNSHolding(s) in Company
23rd Apr 20184:52 pmRNSHolding(s) in Company
20th Apr 20183:27 pmRNSTransaction in Own Shares
20th Apr 201811:34 amRNSDirector/PDMR Shareholding
20th Apr 201811:30 amRNSDirector/PDMR Shareholding
19th Apr 20187:00 amRNSNotice of AGM
6th Apr 20181:59 pmRNSHolding(s) in Company
15th Mar 20183:44 pmRNSHolding(s) in Company
15th Mar 20183:40 pmRNSHolding(s) in Company
9th Mar 20187:00 amRNSPreliminary results, year ended 31 December 2017
5th Mar 20187:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.